Resolution: standard / high
Figure 2.
Gene transfer efficiency of the rAAV capsid mutant (EARVRPP; 
) and a standard rAAV2-based vector (□) on primary human CML and CD34+ PBPC (in % GFP+ cells) using an MOI of 100. Data are given as mean ± SD (n ≥ 4).
) and a standard rAAV2-based vector (□) on primary human CML and CD34+ PBPC (in % GFP+ cells) using an MOI of 100. Data are given as mean ± SD (n ≥ 4).Stiefelhagen et al. Genetic Vaccines and Therapy 2008 6:12 doi:10.1186/1479-0556-6-12
Download authors' original image